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[571 ABSTRACT 
The method for assessing risk of an adverse clinical event 
includes detecting a physiologic signal in the subject and 
determining from the physiologic signal a sequence of 
intervals corresponding to time intervals between heart 
beats. The long-time structure of fluctuations in the intervals 
over a time period of more than fifteen minutes is analyzed 
to assess risk of an adverse clinical event. In a preferred 
embodiment, the physiologic signal is an electrocardiogram 
and the time period is at least fifteen minutes. A preferred 
method for analyzing the long-time structure variability in 
the intervals includes computing the power spectrum and 
fitting the power spectrum to a power law dependence on 
frequency over a selected frequency range such as IO4 to 
IO-' Hz. Characteristics of the long-time structure fluctua- 
tions in the intervals is used to assess risk of an adverse 
clinical event. 
56 Claims, 6 Drawing Sheets 
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METHOD AND APPARATUS FOR 
ASSESSING CARDIOVASCULAR RISK 
The Government has rights in this invention pursuant to 
National Institutes of Health (NIH) grant HL-39291 from 
the National Heart, Lung. and Blood Institute. Bethesda. 
Md. and by NASA Grant NAGW-3927. 
BACKGROUND OF THE lNVENTION 
This invention relates to methods and apparatus for 
assessing risk of an adverse clinical event. An adverse 
clinical event includes. but is not limited to- adverse car- 
diovascular events such as Occurrence of serious heart 
rhythm disturbances such as ventricular tachycardia and 
ventricular fibrillation. myocardial infarction, sudden car- 
diac death. myocardial infarction, development of heart 
failure, stroke. etc; an adverse clinical event may include as 
well other adverse events such as death from any cause. loss 
of consciousness, development of diminished cerebral 
function. development of a condition requiring 
hospitalization, etc. 
The interbeat interval of the heart fluctuates in time. The 
variability in the interbeat interval can arise from a number 
of Merent physiologic mechanisms. One Primary mecha- 
nism normally involved in generating the variability in the 
interbeat interval is the modulation of the activity of the 
sino-atrial node by the autonomic nervous system The 
autonomic nervous system can alter the firing rate of the 
sino-atrial node. which functions as the heart’s n o d  
pacemaker responsible for the initiation of the heartbeat. In 
addition, variation in interbeat interval can be caused by 
circulating catecholamines which modulate the firing rate of 
the sino-atrial node. Variation in interbeat interval can also 
relate to variation in the time required for the electrical 
impulse to conduct through the heart’s conduction system. 
Also, heart beats which originate at abnormal sites in the 
heart (i.e.. not the sino-atrial node) generally are associated 
with substantial variation in the interbeat intervals that end 
or begin with those beats. Such abnormal. or ectopic, beats 
can often be recognized in that they are frequently associ- 
ated with electrocardiographic waveforms of abnormal 
shape. In practice a normal beat may be identified by 
determining whether the shape of the associated electrocar- 
diographic waveform is within n o d  limits and whether 
the interbeat intervals ending and beginning with that beat 
are within normal limits. The interval between two n d  
beats is termed an NN interval. 
Since much of the variability in the interbeat interval in 
normally conducted heart beats is associated with the ongo- 
ing modulation of the sino-atrial node by the autonomic 
nervous system. analysis of variability in interbeat intervals 
(or equivalently, analysis of variability in heart rate which is 
proportional to the reciprocal of the interbeat interval) has 
been used to assess autonomic nervous system function. In 
the remainder of this document reference to variability in 
interbeat interval should be construed to include variability 
in any quantity, such as h a  rate, which may be derived 
from the interbeat intervals. The sequence of interbeat 
intervals may be conveniently obtained from analysis of 
physiologic signals such as the electrocardiogram or the 
arterial blood pressure using techniques well known in the 
art. For example, the interbeat intervals may be measured by 
measuring the intervals between R waves (RR intervals) in 
the electrocardiogram signal. Furthermore, the RR intervals 
of the electrocardiogram can be easily and accurately mea- 
sured from portable recording devices which monitor the 
2 
electrocardiogram over periods of many hours, or even one 
or more days, in ambulatory subjects. Thus analysis of 
interbeat interval variability is a convenient and readily 
available noninvasive approach to assessing autonomic ner- 
Interbeat interval variability has been analyzed in a num- 
ber of difFerent ways. One class of techniques which has 
been used to analyze variability in the interval between heart 
beats involves time domain analysis. In this approach, one 
analyzes the variability in the interbeat intervals over time. 
or equivalently over beat number. Examples of time domain 
measurements include the measurement the standard devia- 
tion or variance of the interbeat intervals over a time period, 
the distribution density function of interbeat interval mag- 
nitudes (the proportions of intervals falling within sequential 
inmemental ranges of interbeat interval) over a time period, 
and the serial autocorrelation coefficients of the interbeat 
intervals over a time period. 
Another class of techniques that have been used to 
analyze interbeat interval variability involves frequency 
2o domain analysis. In the this class of techniques the variabil- 
ity in the interbeat intervals is represented in the frequency 
domain. often using Fourier transform methods. One 
example of frequency domain analysis involves computa- 
tion of the power spectrum (often termed the power spectral 
25 density) of fluctuations i n  interbeat interval. or other signals 
which may be derived from the interbeat interval sequence. 
Power spectra computed from short data segments, approxi- 
mately 5 minutes in length, of interbeat interval data gen- 
erally provide information on the frequency content of the 
30 interbeat intervals above approximately 0.01 Hertz. Such 
power spectra. see mG. loa, are found to often have a peak 
at the frequency of respiration which generally falls in the 
0.15 to 0.40 Hertz range of frequencies. This peak. termed 
the high frequency (HF) peak, has been found to reflect 
activity of the parasympathetic limb of the autonomic ner- 
vous system. An additional peak, termed the low frequency 
(LF) peak is often found in the 0.04 to 0.15 Hertz band. This 
peak has been found to reflect activity of the sympathetic 
limb of the autonomic nervous system as well as the 
parasympathetic limb. The ratio of the areas within these 
two frequency bands (LF/HF ratio), representing the ratio of 
the energies of the fluctuations within these two frequency 
bands, has been used as a measure of the balance between 
sympathetic and parasympathetic activity. 
In addition to computation of the power spectrum over 
short periods of time, longer term recording of interbeat 
interval data have been analyzed using frequency domain 
techniques. For example, the power spectrum analysis of 24 
5o hour recordings of interbeat interval data have been per- 
formed Such analyses, see for example FIG. lob. reveal 
that, at frequencies below approximately 0.02 Hertz down to 
approximately Hertz, the relationship between the 
logarithm of the power spectrum amplitude and the loga- 
55 rithm of the frequency is described by a straight line. This, 
as shown below. is equivalent to the relationship given by 
the following equation: 
where P is  the power spectral density, C is a proportionality 
constant. f is frequency and ct is a negative exponent. This 
relationship is termed a power law dependence of spectral 
power on frequency. Taking the logarithm of the above 
equation, one obtains: 
where log denotes the logarithm function. This demonstrates 
that the linear relationship between the logarithm of the 
5 vous system function. 
35 
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power spectrum and the logarithm of frequency is equivalent sively obtained even in ambulatoIy subjects, what is needed 
to a power law relationship between the magnitude of the is a more effective means of analyzing interbeat interval 
power spectrum and frequency. The slope of the linear variability to accurately assess an individual's risk of an 
relationship is in fact equal to the exponent a. This depen- adverse clinical event. 
dence of the power spectrum on frequency at frequencies 5 
below approximately 0.02 Hertz, was not previously known S-Y OF THE INVENTION 
to be associated with the risk of future adverse clinical and apparatus for assess- 
events. ing risk of an adverse clinical event by analysis of variability 
A variety of techniques have been used to analyze vari- in hmals between h& beats in of the l o n g - h e  
ability in  interbeat interval to assess risk of an adverse 10 structure of fluctuations of the interbeat intervals. 
clinical event. For example, some of these techniques The method of the invention, in one aspect, includes involve obtaining measures of the distribution of the mag- detecting a physiologic signal in a subject and 
nitudes of the interbeat intervals such as the standard devia- from the physiologic signal a sequence of intervals corre- 
tion of the NN intervals (SDNN), the integral of the distri- sponding to time intervals bemeen h a  beats. Long-time 
bution density function of NN intervals divided by the 1s structure of in the intervals over a time period of 
maximum of the distribution density function (HRV Trian- than minutes is to aSSeSS risk of an 
the distribution density function (TINN-triangular inteapc- physio~ogic signal is an electrocardiogrm and the he lation of NN interval histogram). Other techniques which is at least one hour. embodiment includes involve segmentation of the data include the measurement of 20 computing the power specbrum and the amplitude of the 
the difference between the average of the NN intervals at frequency is estimated. A 
(Night-Day Difference), the mean of the standard deviations the power 
Of the NN within ('Dm spectrum to a power law dependence on kquency over a 
Index). the standard deviation of the average of the NN 25 selected frequency range such as apFoximately 10-4 to 10-2 
weighted by the fraction of the 5 minutes that has normal RR 
intervals---(SDANN Index). Other techniques involve mea- 
surements related to the relationship between the lengths of 
adjacent normal interbeat intervals. Such measures include 30 
ms invention relates to 
gular Index). baseline width Of a to adverse clinical event. In a preferred the 
power spectrum at a 
method of the invention may also include 
'at and the average Of the NN during the suitable specified frequenq is approximately lo4 Hz. The 
intervals within average being Hz. The amplitude of the power law dependence is deter- 
mined at a 
In yet another embodiment of the invention the method 
further includes fitting the logarithm of the power spectrum 
whose lengths differ by more than fifty millisec- selected frequency range such as approximately lo" to Hz. In this embodiment, the amplitude of the linear depen- onds (NN50. pNNS0 or pNNSO% respectively), and the root dence is determined at a specified frequency. In this mean square successive difference of normal RR intervals (rMSSD). other techniques involve compu~tion of the 35 embodiment. the risk of an adverse clinical event is detex- 
mined by comparing the amplitude of the power spectrum energy in various frequency bands of the power spectrum of 
Gordon, with a predetermined risk-related cutpoint amplitude. Risk 
sis of Heart Rate - Transactions on Bie power law dependence with a predetermined risk-related 
medical Engineering. 33:900-904. 1986). Measures 40 cutpoint amplitude' Further' the exponent characterizing the 
obtained with such techniques the energy in the power law dependence is compared with a predetermined 
power specmm up 
power spectrum up to 0.0033 H~ (w-mtra L~~ In another aspect. the invention includes determining a 
Frequency-Power), energy in the power spectrum between frequency the selected frequency range at Which 
0.0033 and 0.04 Hz (Very Low frequency-wqower). 45 Of the linear dependence has a low correlation 
energy in the power between 0.04 and 0.15 H~ with the slope of the linear dependence when applied to a 
(Low Frequency-LF-Power), energy in the power spec- reference F'CFulation* 
m m  between 0.15 Hz and 0.40 Hz (High Frequenq-m- In yet another aspect Of the invention the method for 
power), ratio of a d  power (LF/HF Ratio). m e  assessing risk of an adverse clinical event includes detecting 
W/HF ratio was computed because it was thought to be a 50 an electrocardiogram Signal in a subject and determining 
measure of syrnpathetidparasympathetic balance. not as a from the electrocardiogram a sequence Of intervals come- 
means to measure the structure of the power spectrum. sponding to time intervals between heartbeats. The power 
Alterations in autonomic tone are thought to be associated Spectrum Of the sequence Of intervals Over a time m o d  of 
with physiologic states associated with altered cardiac state. more than S i x  hours is computed and the logarithm of the 
For example. patients with heart failure are known to have 5s Power Spectrum is fitted to a linear dependence on the 
diminished parasympathetic nervous system activity (one logarithm of frequency over the frequency range of aPpr0~-  
component ofthe autonomic nervous system), and enhanced mately lo" to Hz. Risk of an adverse clinical event is 
levels of sympathetic nervous system activity (another con- based on one or more characteristics of the linear depen- 
ponent of the autonomic nervous system). Both have been dence. Suitable characteristics include Slope of the linear 
shown to enhance susceptibility to life threatening heart 60 dependence and amplitude of the linear dependence at a 
rhythm disturbances. Previous measures derived from analy- specified frequency. 
ses of interbeat intend variability have shown some rela- In one preferred embodiment, long-time structure of fluc- 
tionship to the subsequent occurrence of adverse clinical tuations in interbeat intervals is characterized by computing 
events. These measures. however, do not predict an indi- the serial autocorrelation coefficients of the interbeat inter- 
vidual's risk of an adverse clinical event with suEicient 65 vals; in another preferred embodiment the interbeat intervals 
accuracy to justify therapeutic intervention. Since the are converted to a time-based signal and the autocorrelation 
sequence of interbeat intervals may be easily and noninva- function of the signal is computed. The long-time stzucture 
the propodon or pacent of adjacent n& RR to a linear dependence On the logarithm Of Over a 
intervals (see Berger R. ,. hehod 
and Cohen R. J. *'h mcientfigkthm for spectral h a l y -  mY also be assessed by CO-g the amplitude of the 
0.40 & pod Power), energy in the risk-related cutpoint exponent to assess risk. 
FIGS. l(a). l(b) and l(c) are log-log graphs of 24-hour 
RFt power spectra. The computer power law regression lines 
are superimposed on the data; the solid portions of the lines 
are the segments between lo4 and lop2 Hz. The left panel 
shows data from a healthy subject, the middle panel shows 
data from a patient 11 days after myocardial infarction, and 
the right panel shows data from a heart transplant patient 
(denervated heart). For each example. total power (ms2) was 
near the median for the group. 
5,755 -67 1 
5 6 
is then analyzed by examining the dependence of the aut* 
correlation coefficients on delay-number, or autocorrelation 
function on delay-time. at delays corresponding to approxi- 
mately one minute or longer. In another preferred 
embodiment, the power spectrum of the fluctuations in 
interbeat interval is computed and the dependence of the 
power spectrum on frequency at frequencies below approxi- 
mately 0.02 Hertz is analyzed. The power spectrum may be 
estimated by many techniques well known in the art such as 
Fourier transform methods, autoregressive moving average 
methods, and the like. In another preferred embodiment. 
complex demodulation is used to define the long-time struc- 
ture of the fluctuations in the frequency domain. 
In other preferred embodiments, many other techniques 
known in the art are used to analyze the long-time structure 
of fluctuations in interbeat interval either in the time domain, 
frequency domain, or other domains. For example, in one 
preferred embodiment the variability of interbeat interval is 
analyzed utilizing segments of at least two different lengths. 
One aspect of this embodiment involves analyzing variabil- 
ity within segments. Another aspect involves analyzing the 
variability between segments of a measure of the intervals 
within segments. In one example of this embodiment, the 
interbeat interval sequence is first divided up into segments 
of length a, then divided into segments of length b and then 
into segments of length c and so on. One then computes the 
average standard deviation or variance of NN intervals 
within segments of each length (for example, SDNN-a 
Index. SDNN-b Index, SDNN-c Index. etc). Analysis of the 
dependence, for example, of the SDNN Index. on segment 
length provides information on the long-time structure of the 
fluctuations. In another aspect of this embodiment, one 
computes. for Werent segment lengths, the standard devia- 
tion of the average of the NN intervals in each segment (Le. 
SDANN-a Index, SDANl’4-b Index. SDANN-c Index). The 
dependence of the SDANN Index on segment length pro- 
vides information on the long-time structure of the fluctua- 
tions. 
In another preferred embodiment, the energy of the fluc- 
tuations in two or more frequency bands. at least one 
including a region below 0.02 Hertz. are computed (for 
example by computing and integrating the power spectrum 
over these bands. or by band-pass filtering a signal related to 
the interbeat intervals). The dependence of energy on fre- 
quency band is analyzed to characterize the long-time stmc- 
ture of the fluctuations and thereby to assess risk of an 
adverse clinical event. For example. the ratio or ditference of 
energy in the two frequency bands is computed to obtain a 
measure of risk of an adverse clinical event. In another 
preferred embodiment, the power of the fluctuations at two 
or more frequencies, at least one of which is below 0.02 
Hertz. are computed (for example by computing and mea- 
suring the amplitude of the power spectrum at these 
frequencies. or by notch filtering a signal related to the 
interbeat intervals). The dependence of power on frequency 
is analyzed to characterize the long-time structure of the 
fluctuations and thereby to assess risk of an adverse clinical 
event. For example. the ratio or d8erence of power at the 
two frequencies is computed to obtain a measure of risk of 
an adverse clinical event. 
It is understood that the method of this invention includes 
all techniques that may be used to analyze the long-time 
structure of fluctuations in interbeat interval in order to 
assess risk of an adverse clinical event (for example, meth- 
ods involving computation of autoregression coefficients, 
complex demodulation, transform methods. wavelet expan- 
sions and the like). 
BRIEF DESClUlTION OF THE DRAWINGS 
FIG. 2 is a graph of regression of logewer)  on log 
(frequency) for healthy subjects (n=274). myocardial inf- 
arction patients (n=715), and heart transplant patients (n-19). 
15 Each regression line is the average of the regression lines for 
all subjects in a group. Each confidence band is the average 
of the 95% confidence bands for all subjects in a group. For 
the healthy group, power drops approximately one log unit 
for each log unit increase in  frequency. For the heart 
2o transplant group. power drops approximately two log units 
for each log unit increase in frequency. The average slope for 
the myocardial infarction group has a value between the 
healthy group and the heart transplant group. The changes in 
slope in the myocardial infarction group and the heart 
25 transplant group indicate relatively greater loss of power at 
higher frequencies compared to the healthy group. 
FIGS. 3(a)-U, are graphs comparing frequency distribu- 
tions of two power law regression parameters. slope (FIGS. 
3(a)-(c)) and power at lo4 Hz (FIGS. 3144)) among three 
3o groups: healthy subjects (n=274), myocardial infarction 
patients (n=715), and heart transplant patients (n=19). Note 
that the distributions of both measures shown for myocardial 
infarction patients are wider, i.e., extend further to the left, 
than those for healthy subjects or heart transplant patients. In 
35 the heart transplant group. the distribution for slope values 
is narrow and shifts far to the left; there is little overlap with 
slope values for the myoardial infarction group and no 
overlap with slope values for the healthy group. 
FIG. 4 is a graph showing correlation between slope and 
40 log(p0wer) on the y-axis as a function of frequency on the 
x-axis, among the 715 power law regression equations of the 
myocardial infarction group. As frequency ranges from lo-’ 
Hz to 1 Hz, this function is S-shaped. For lower values on 
the abscissa, the computer power has a negative correlation 
45 with slope; for higher values. a positive correlation. At 
10-3.594 Hz, the correlation equals zero. 
FIG. 5 includes Kaplan-Meier survival curves for 715 
myocardial infarction patients aoss-classified by optimum 
cutpoints for slope on the power law regression line 
Hz 
(dichotomized at 6.345). The 3-year survival rates were: for 
patients in neither high-risk category, labelled “Neither.” 
89%; for patients in the high risk category for low (power) 
at 10-4 Hz only, labelled ‘zOg@ower) at 10-4 Hz,” 70%; for 
55 patients in the high risk category for slope only, labelled 
“Slope,” 64%; for patients in the high-risk category for both 
variables, labelled “Both.” 17%;. The survival curve 
labelled “Log@Ower) at lo4 Hz” is thinner than the other 
three curves. to distinguish it from the survival c w e  
60 labelled “Slope.” For each of the four groups, the numbers 
of patients being followed at enrollment and at 1.2. and 3 
years is shown below the graph. 
FIG. 6 includes Kaplan-Meier survival curves for 715 
myocardial infarction patients cross-classified by optimum 
65 cutpoints for slope of the power law regression line 
(dichotomized at -1.372) and zero-correlation log(p0wer) 
(dichotomized at 5.716). The 3-year survival rates were: for 
50 (dichotomized at -1.372) and log@ower) at 
5.755.671 
7 8 
patients in neither high-risk categov. labelled “Neither.” 
89%; for patients in the high risk categoy for zero- 
correlation log@ower) only, labelled “Log(power) at 
Hz,” 67%; for patients in the high risk category for 
slope labelled “slope,” 67%; for patients in the high- 
risk category for both v-bles. labelled -~~th,* ’  21%;. me 
survival Curve labelled ~zog@ower) at 10-3 594 ~ ~ 3 9  is 
thinner than the other three curves, to distinguish it from the 
survival curve labelled “Slope.” For each of the four groups. 
the numbas of patients being followed at enrollment and at 10 
1, 2. and 3 years is shown below the graph. 
decreased log@ower) at lo4 Hertz, had a three year mor- 
tality of 83%. whereas 470 patients determined to be at ‘low 
risk’. because each had a less negative slope and higher 
lOg@OWer) at lo4 Hmz, had a three Year mortality of O d Y  
11%. Thus the 21 patients found to be at ‘high risk’ accord- 
ing to the method of th is  invention had approximately a 7.5 
times greater risk of mortality compared to the 470 patients 
found to be at ‘low risk’ according to the method of this 
invention. 
On 
frequency expresses a relationship indicating a consistent 
increase in the power of fluctuations in interbeat interval as 
5 
The POwer law dependence Of the power 
FIG* is a graph the between frequency decreases at frequencies below appro-tely 
0.02 Hertz. This invention involves the &covery that the 
bands for a 15 shape of the power spec-, i.e. the dependence of the 
regression Of Power 
mations On and 
density for RR 
power spectrum on frequency, at frequencies below approxi- healthy subject. The computed power law regression line is 
supaimposed On the data; the darkened Of the lines mately 0.02 Hertz is directly related to the risk of an adverse is the segment between 10-4 and lo-’ Hz. ULF. ultra low clinical event such as mortality. The repre- 
the region Of the ULF and VLF bands’ the graph Of 2o properties of fluctuations in interbeat interval at frequencies 
spectral power versus frequency is linear. In the region of the below approximately o.02 Hertz. The power may LF and the HF bands’ the be computed according to a wide variety of techniques such 
gressive techniques and other methods known in the art. autonomic nervous system. 
FIG. 8 is a schematic illustration of a human subject 25 other frequency that could be equivalently 
instrumented with electrodes for recording electrocardb used to measure the of fluctuations in interbeat 
graphic activity and a portable recording apparatus. interval at frequencies below approximately 0.02 Hertz 
FIG. 9 is a schematic illustration of the apparatus for include, for example, sine or cosine transform methods, or 
carrying out the present invention. complex demodulation. 
FIG. loa is a graph of a heart rate power specbum 3o The properties of fluctuations in interbeat interval at 
obtained on a standing human subject from a short, 256 frequencies below 0.02 Hertz, relate to the behavior of the 
second, data segment. This spectrum which approximately fluctuations over long periods of time. Long periods of time 
covers a 0.014.5 Hertz frequency range demonstrates the refer in th is  document refer to time periods on the order of 
presence of the low frequency (LO-FR) and high-frequency one minute or longer, corresponding to frequencies less than 
(HI-FR) peaks. This figure is taken from Pomeranz B, 35 approximately 0.02 Hertz. Thus propexties of fluctuations in 
Macaulay J. B., Caudill M. A., Kutz I. Adam D. Gordon D, interbeat interval at frequencies below approximately 0.02 
Kilborn K. M., Barger A. C., Shannon D. C.. Cohen R J., Hertz,. such as the power law dependence of the power 
Benson H. American Journal of Physiology 1988348, spectrum on frequency, relate to the long-time structure of 
H151-Hl53. the fluctuations in interbeat interval. To examine the long- 
FIG. lob is a graph of a heart rate power spectrum 40 time structure of the fluctuations one generally requires a 
 ut^ from interbeat interval &a taken from a 24 horn sequence Of interbeat intervals COITeSpO~ding to a data 
ECG recording of a human subject. The graph shows the record of a length which is a large multiple of one minute- 
linear relationship between spectral density and frequency generally at least 15 minutes. 
when plotted on a log-log plot o v a  at least three decades This invention relates to methods and apparatus for 
of frequency above lo-’ Hertz. This figure is taken from 45 assessing risk of an adverse clinical event by analysis of the 
Saul J. P.. Albrecht P. Berger R D. and Cohen R J., long-time structure of fluctuations in interbeat interval. The 
Computers in Cardiology Conference Pn>ceedings in Leu- analysis of the long-time structure may be performed in the 
ven Belgium, Sep. 12-15. 1987, Computer Society Press, frequency domain as described above. in the time domain 
Washington. Los Alamitos. Brussels. (for example by autocorrelation analysis), or using other 
50 means for representing the fluctuations (for example, using 
DESCRIPTION OF THE PREFERRED polynomial expansion, wavelet representation. Laplace or 
EMBODIMENT other transform methods. etc.). All these methods can pro- 
This invention relates to the assessment of risk of an vide information on the s t r u c m  Of long-time fluctuations in 
advase clinical event by analysis ofthe long-time structure interbeat interval. This structure refers to the shape of the 
of fluctuations in interbeat interval. The inventors discov- 55 fluctuations, for example the waveform of a fluctuation as it 
ered that the power law dependence of the power spectrum evolves over a period of time. In the frequency domain, the 
on frequency at frequencies below approximately 0.02 structure of a fluctuation reflects the dependence on fre- 
H&. which is re-hble in that the relationship is con- quency of the Fourier transform of the waveform of the 
sistent over at least three decades of frequency, provides fluctuation. 
extremely accurate information on the risk of an adverse 60 Previously used techniques used to analyze interbeat 
clinical event. In particular the risk of a future adverse interval variability to assess risk of adverse clinical events 
clinical event increases strongly as the logarithm of the described above in the Background of the Invention. do not 
power law relationship at a given fkequency decreases and characterize structure of fluctuations in interbeat interval 
the slope becomes more negative. For example, in a group over long periods of time (long-time structure). These tech- 
of 715 patients after myocardial infarction, as shown in the 65 niques do not analyze information related to the sequence in 
Example below-see FIG. 5.21 patients determinedto be at time of the fluctuations in the intemals-except perhaps 
‘high risk’, because each had a highly negative slope and over short periods of time or by measuring the energy of 
frequency; low high frequency* In sents one frequency domain technique for measuring the 
graph Of spectral 
versus frequency is non-linear due to modulation by as metho& involving the use of F-er transforms, autore- 
5,755.671 
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fluctuations in a frequency band or by measuring night-day dependence, for example. of the SDNN Index, on segment 
differences in an average rneasure4nd thus do not consti- length provides information on the long-time structure of the 
tute methods for assessing long-time structure of the vari- fluctuations. In another aspect of this embodiment, one 
ability in interbeat intervals as hereby defined in this docu- computes. for different segment lengths. the standard devia- 
merit. some Of the Previous techniques discussed above 5 tion of the average of the NN intervals in each segment (Le. 
characterize the distribution of magnitudes of interbeat SDANN-~ Index, S D m - b  Index. SDANN-~ hdeX). ne 
intervals (such as SDNN, total Power). measwe the energy dependence of the SDANN Index on segment length pro- 
of fluctuations in a frequency band (such as ULF or w vides informtion on the long-time structure of the fluctua- 
power) or over particular time periods (such as SDNN Index tions. 
structure of the fluctuations as they evolve over time. The tuations in two or more frequency bands. at least one LF/HF ratio is a measure of the short time-structure of the including a region below o.02 Hertz. are computed (for fluctuations in  intabeat interval but not long-time structure. example by computing and integrating the power spectrum 
To analyze the structure Of interval fluctuations One over these bands. or by band-pass filtering a signal related to 
frequency domain Or in Other domains reflecting Other quency band is analyzed to characterize the long-time struc- 
representations of the fluctuations. Structure analysis gen- ture of the fluctuations and thereby to clinical risk 
For example, the ratio or difference of energy in the two erally involves a minimum of two measures of the fluctua- 
structure refers to the evolution of the fluctuations for times 2o an adverse clinical event. In preferred embodiment, scales approximately on the order of a minute or longer. In the power of the fluctuations at two or more frequencies, at 
example by computing and measuring the amplitude of the than roughly 0.02 Hertz. 
This invention relates to the analysis of the long-time power at these fiequendes, (x by filtering a 
structure of the variability in interbeat interval to assess risk 25 intervals). The dependence of 
of an adverse clinical event. This invention is based on the power on frequency is analyzed to characterize the long- 
that information re’ated to the risk Of future time structure of the fluctuations and thereby to assess 
adverse clinical events is contained in the long-time stnrc- clinical risk For the ratio or merence of power at 
the two frequencies is computed to obtain a measure of risk ture of fluctuations in interbeat interval. 
structure of the fluctuations in interbeat interval is analyzed According to the method of the invention the recording of 
the physiologic signal from the subject may be performed to assess risk of an adverse clinical event. In one preferred embodiment. long-time structure in interbeat interval is while the patient is resting, ambulating or engaged in characterized by computing the serial autocorrelation coef- an activity protocol. ficients of the interbeat intervals; in another preferred 35 
to a time- It is understood that the method of this invention includes 
based signal and the autocorrelation function of the signal is all techniques that may be used to analyze the 
c o q u t ~ .  The long-he structure is then by structure of fluctuations in interbeat interval in order to 
the dependence of the autocomelation mfi- assess risk of an adverse clinical event (for example, meth- 
cients on & l a y - n u ~ a ,  autocorrelation fundon n ods involving computation of autoregression coefficients, 
delay-time, including delays corresponding to approxi- complex demodulation. transform methods, wavelet expan- 
the power spectrum of the fluduations in ment of the invention which illustrates the great power of the 
interbeat interval is computed and the dependence of the invention for assessing risk of an adverse clinical event from 
power spectrum on frequency at frequencies LAOW approxi- 45 *e analysis of interbeat interval variability. 
mately 0.02 Hertz is analyzed. The powex spectrum may be The following portion of the Description of the Referred 
estimated by many techniques well known in the such as Embodiment up to the discussion of the apparatus -le- 
Fourier transformmethods, autoregressive methods. and the menting the present invention constitutes the verbatim text, 
&e. In another embodiment, complex demodula- figures and tables from a muscript  entitled “Power Law 
tion is used to define the long-time stnrcture of the fluctua- 50 Behavior of RR Interval Variability in Healthy Middle-Aged 
tions in the frequency domain. Persons. Patients with Recent Acute Myocardial Infarction, 
and Patients with Heart Tr:anspliUlts” by J. Thomas Bigger. 
Jr., Richard C. Steinman. Linda M. Rolnit~k~. Joseph L. 
Fleiss. Paul Albrecht, and Richard J. Cohen Submitted for 
or ’Dm Index)* but do not characterize the 10 In another preferred embodiment. the energy of the flue- 
analyze the shape Of the in the time in the 15 the interbeat intervals), The dependence of energy on fie- 
tion in the time, frequency Or Other domains‘ The frequency ban& is to obtain a measure of risk of 
the domain, this to frequencies less least one of which is below 0.02 Hertz, are computed (for 
to the 
According to the method of this invention long-time 30 of an adverse event. 
the interbeat intervals are 
mately one minute or longer. In another preferred sions and the like) Below we present one Preferred ~ ~ b d -  
~n other preferred embodiments, m y  other techniques 
hewn in the me us& to analyze the longtime structure 
of fluctuations in interbeat internal either in the time domain. 
frequency domain, or other domains. For example, in one 55 Publication. 
preferred embodiment the variability of interbeat interval is The theories and experiments on which the present inven- 
analyzed utilizing segments of at least two different lengths. tion is based will now be discussed. In 1982, Kobayashi and 
One aspect of th is  embodiment involves analyzing variabil- Musha reported the frequency dependence of the power 
ity within segments. Another aspect involves analyzing the specirum of RR interval fluctuations in a normal young man. 
variability between segments of a measure of the intervals 60 Kobayoshi. M. et al.. “l/f Fluctuation of Heartbeat Period.” 
within segments. In one example of th is  embodiment, the IEEE Trans. Biomed, Eng. BME, 29456-457, 1982. They 
interbeat interval sequence is first divided up into segments computed the power spectnun of a 10-hour recording of FtR 
of length a. then divided into segments of length b and then intervals made in a laboratory setting and plotted the result- 
into segments of length c and so on. One then computes the ing power and frequency on a log-log graph. Over a 
average standard deviation or variance of NN intervals 65 frequency range from 0.0001 Hz to 0.02 Hz, they found that 
within segments of each length (for example, SDNN-a the plot was described by a straight line with a slope 
Index, SDNN-b Index, SDNN-c Index. etc). Analysis of the approximately equal to -1: indicating that the power 
5,755.671 
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decreased approximately as the reciprocal of frequency, l/f. 
In 1988. Saul et al. performed power spectral analyses of 
24-hour ambulatory ECG recordings from five healthy 
young men and found that over about four decades of 
frequency (0.00003 to almost 0.1 Hz) that the power spec- 
trum’s dependence on frequency is described by a power 
law 
P=CP (1) 
where P is the power spectral density, f is frequency. a is a 
negative exponent. and C is a proportionality constant, Saul, 
J. F! et al. “Analysis of Long Term Heart Rate Variability: 
Methods. l/f Scaling and Implications.” Computers in 
Cadiology, IEEE Computer Society Press. 14:4 19-422 
(1987); a also corresponds to the slope of the log P versus 
log f relationship 
log =log C&gP (2 )  
With spectral power and frequency both plotted on log 
scales. the slope of therelationship was about -1; Saul et al. 
found that a averaged -1.02W.05 and ranged from -0.93 to 
-1.07 in healthy young men. 
Experiments were designed and d e d  out by the inven- 
tors herein (1) to establish normal values for the regression 
of spectral power on frequency for RR interval fluctuations 
in  healthy middle-aged persons; (2) to determine the effects 
of myocardial infarction on the regression of log@ower) on 
log(frequency); (3) to determine the effect of cardiac den- 
ervation on the regression of log@ower) on log(frequency); 
and (4) to assess the ability of power law regression param- 
eters to predict death after myocardial infarction. 
Patient groups 
We studied three groups: (1) a group with recent my+ 
cardial infarction; (2) a group of healthy middle-aged per- 
sons matched on age and sex to the infarct sample; and (3) 
a group of patients with heart transplants. The patients with 
myocardial infarction were participants in the Multicenter 
Post Infarction Program (MPIP), a prospective natural his- 
tory study of myocardial infarction. The Multicenter Post 
Infarction Research Group. “Risk Stratification and Survival 
After Myocardial Infarction,” N Eng. J. Med. 3W.33 1-336. 
1983; Bigger, J. T. et al. ‘The Relationships Among Ven- 
tricular Arrhythmias, Left Ventricular Dysfunction and Mor- 
tality in the 2 Years After Myocardial Infarction,” Circula- 
tion 69:250-258. 1984. The MPP sample of patients was 
selected to be representative of the entire myocardial inf- 
arction population. The details concerning enrollment, mea- 
surement of baseline variables, quality control procedures 
and follow-up have been descriied previously. The 24-hour 
electrocardiographic recordings were made 11s days after 
acute myocardial infarction. The sample of healthy persons 
was recruited to match the myocardial infarction sample for 
age and sex. Bigger, J. T. et al. “RR Variability in Healthy, 
Middle-Aged Persons Compared with Patients with Chronic 
Coronary Heart Disease of Recent Acute Myocardial 
Infarction,” Circulation 91:193&1943, 1995. The group of 
patients with heart transplants were participants in a study of 
psychoactive responsiveness (6). They were 47 f l l  years of 
age and were studied between 3 and 4 months after their 
heart transplant. Transplant patients were excluded for 
hypertension (blood pressure>160/100). heart failure, or 
transplant rejection. 24-Hour ECG recordings were made 
with patients off all adrenergic agonist or antagonist medi- 
cation or psychoactive drugs. but all were taking cyclosporin 
and prednisone. 
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Study design 
To determine the effects of acute myocardial infarction on 
the regression of log@ower) on log(frequency) of RR 
fluctuations. we compared the healthy group with the 
patients with recent myocardial infarction. To determine the 
effect of cardiac denervation on the regression of log@ower) 
on log(frequency) of RR fluctuations, we compared the 
healthy sample with the heart transplant patients. 
Processing of %-Hour Holter Recordings 
We processed 24-hour Holter tape or cassette recordings 
using recently described methods. Briefly, the 24-hour 
recordings were digitized by a Marquette 8000 scanner and 
submitted to the standard Marquette algorithms for QRS 
labeling and editing (version 5.8 software). Then, the data 
fdes were transferred via high speed link from the Marquette 
scanner to a Sun 4/75 workstation where a second stage of 
editing was done. using algorithms developed at Columbia 
University, to find and correct any remaining errors in QRS 
labeling that could adversely affect measurement of RR 
variability. Bigger et al., “Components of Heart Rate Vari- 
ability Measured During Healing of Acute Myocardial 
Infarction,” Am. J. CurdioZ. 61:208-215. 1988. Long and 
short RR intervals in all classes, normal to normal. normal 
to atrial premature complex, normal to ventricular premature 
complex, were reviewed iteratively until all errors were 
corrected. For a tape to be eligible for t h i s  study, we required 
it to have L 12 hours of analyzable data and have at least half 
of the nighttime (00:00-05:00) and daytime (07:30-21:30) 
periods analyzable. At least 50% of each period had to be 
sinus rhythm. Bigger et al., “Correlations Among Time and 
Frequency Domain Measures of Heart Period Variability 
Two Weeks After Myocardial Infarction,” Am. J.  Cardiol. 
69:891-898,1992. The average duration of the ECG record- 
ings was 223 hours for the three samples and 3 9 %  of all 
RR intervals were consecutive n o d  complexes. 
Time Series Analysis of Normal RR Intervals 
Frequency Domain Analysis. Mer the second stage of 
editing and review of the results by a cardiologist, the RR 
interval power spectrum was computed over the entire 
recording interval (usually 24 hours) using a method first 
described by Albrecht and Cohen, “Estimation of Heart Rate 
Power Spectrum Bands from Real-World Data: Dealing 
With Ectopic Beats and Noisy Data,” Computers in Cadi- 
ology 15:311-314, 1988. Our adaptation of the method was 
described by Rottman et al., “EEcient Estimation of the 
Heart Period Power Spectrum Suitable for Physiology or 
Pharmacologic Studies,” Am. J.  Caniiol. 6 6  1522-1524, 
1990. First. a regularly spaced time series was derived from 
the RR intervals by sampling the irregularly spaced series 
defined by the succession of normal RR intervals. For each 
Holter ECG recording, 2‘’ points were sampled; for record- 
ings precisely 24-hours in duration. the sampling interval 
was 329 ms. A “boxcar” low-pass filter with a window twice 
the sampling interval was then applied Gaps in the time 
series resulting from noise or ectopic beats were filled in 
with linear splines which can cause a small reduction in high 
frequency power but does not affect other components of the 
power spectrum. 
A fast Fourier transform was computed and the resulting 
24-hour RR interval power spectrum was corrected for the 
attenuating effects of both the filtering and the sampling (see 
Albrecht and Cohen. above). Frequency domain measures of 
RR variability were computed by integrating the point 
power spectrum over their frequency intervals as previously 
described. Bigger et al., “Frequency Domain Measures of 
Heart Period Variability and Mortality After Myocardial 
Infarction.” Circulation 85:164-171. 1992. We calculated 
5.755.671 
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the power within four frequency bands of the 24-hour RR 53:457481, 1958, to display graphically the survival expe- 
interval power spectrum: (I) <0.0033 Hz, ultra low fre- rience of the MPIP sample of patients over a %year interval 
quency power (ULF), (2) 0.0033 to <0.04 Hz. very low of time and to tabulate survival rates up to a prespecsed 
frequency power 0.(3) 0.04 to ~0.15 Hz, low frequency time. 3 years. We performed Cox proportional hazards 
power (LF), and (4) 0.15 to <0.40 Hz. high frequency power 5 analyses, see Cox, ‘Regression Models and Life Tables, ” 
(HF). In addition, we calculated total power bower in the (with discussion) J. R. Stat. SOC. B. 34:187-220,1972, when 
band <0.40 Hz) and the ratio of low to high frequency testing hypotheses about the association between one or 
(LF/HF) power. a measure that has been used as an indicator more risk predictors and mortality. The Cox regression 
of sympatho-vagal balance. Pagani et al., “Power Spectral model allowed us to adjust for covariates. The P2L BMDP 
Analysis of Heart Rate andmerial Pressure Variabilities as 10 computer program was used to carry out the Cox survival 
a Marker of Sympatho-Vagal Interaction in Man and Con- analyses. Dixon et al., “BMDP Statistical Software.” Los 
scious Dog.” Circ. Res. 59:178-193, 1986. High values for Angeles: University of California Press, 719-743, 1988. 
the ratio suggest predominance of sympathetic nervous This program permits categorical and continuous predictor 
activity. variables to be analyzed together. The Cox proportional 
Regression and correlation analyses. For each Holter 15 hazards model provides a measure of association, the hazard 
recording. the regression of log@ower) on log(frequency) ratio, that is not linked to a single time point. Cox model 
was computed using previously described techniques (see, survival analysis estimates the independent effects of each of 
Saul. above). Briefly, the point power spectrum described several predictor variables on survival. The hazard function, 
above was logarithmically smoothed in the frequency i.e., the instantaneous probability of dying at any point in 
domain by first calculating the common log of frequency 20 time. is assumed in the Cox model to be proportional to the 
and then integrating power into bins spaced 60 per decade, exponential functions exp(ZB,X,) where the B,’s are the 
i.e.. 0.0167 log(Hz) wide. Because each successive decade regression coefficients and the X,’s are the values of the 
has 10 times the number of points as the previous decade, predictor variables. The values of the regression coefficients 
bins at higher frequency contain more points than those at are assumed to remain constant over time. and each exp(B,) 
lower frequencies. A regression analysis of log@ower) on 25 isinterpretable as a relative risk for variable i: exp(B,) is the 
log(frequency) was performed on the linear portion of the ratio of instantaneous probabilities of dying for patients with 
smoothed power spectrum-between and lo-’ values of X, 1 unit apart, holding all other variables constant. 
Hz-and the slope and intercept at 10-4 Hz derived. We Dichotomizing Predictor Variables. To find the best cut- 
chose this frequency because it is the furthest from the point to dichotomize slope, log@ower) at lo4 Hz, and 
noo-linear portion of the smoothed power spectrum, the LF 30 zero-correlation log@ower), we sought the dichotomization 
and HF power bands. cutpoint that maximized the hazard ratio obtained from the 
Individual regression equations were derived for each of Cox regression models with all-cause mortality as the end- 
the 274 healthy subjects, for the 715 patients with recent point. Given the need for adequate numbers of patients i n  
myocardial infarction, and for the 19 patients with heart each subgroup when testing hypotheses. we restricted our 
transplants. Then. an “average” regression equation was 35 search to dichotomizations from the 10th to 65th percentiles. 
obtained for each of these three groups. For each group. this We calculated the hazard ratio for each possible dichotomi- 
average regression line had, as its slope and lo4 Hz zation cutpoint within t h i s  interval (unadjusted for any 
intercept, the average of the slopes and intercepts of the covariates), and identified the point at which the hazard ratio 
individual regression lines. 95% confidence bands were attained its maximum value. In  addition to Cox analyses 
calculated for each group. Each confidence band was the 40 where all-cause mortality was the endpoint, these dichoto- 
average of the 95% confidence bands for all subjects in a mization cutpoints were used in Cox analyses using cardiac 
group. These group confidence bands were calculated by mortality and arrhythmic mortality as the endpoints. Hinckle 
averaging the values of each individual lower and upper et al.. “Clinical Classification of Cardiac Deaths.” Circula- 
95% confidence band over the range of x-values between tion 65:457464. 1982. 
lo4 Hz and Hz. 45 Association Between Power Spectral Regression Parameters 
For the group with recent myocardial infarction, we andMortality 
wanted an intercept that would be statistically independent We used the Cox proportional hazards survival model to 
of slope and would thus represent an upper limit of predic- determine whether the slope, the log power) at lo4 Hz, or 
tive accuracy to predict mortality. Among the resulting 715 the zero-correlation log(power) predicted all-cause 
regression equations in this group, preliminary examination 50 mortality. cardiac mortality or arrhythmic mortality when 
of the correlation between the slope and values of the used alone or when adjusted for five important post infarc- 
function at different points on the abscissa revealed that for tion risk predictors that we previously found strongly asso- 
selected higher values. e.g. -2 (Le., Hz), the power and ciated with mortality. Slope and the two power measures 
slope had a positive correlation and that for selected lower were dichotomized so that the relative strengths of associa- 
values, e.g. -4 (Le., lo4 Hz), a negative correlation. These 55 tion could be estimated. For these analyses, the additional 
observations implied the existence of at least one point on covariates were coded to provide the best fitting model to 
the abscissa where the correlation between logbwer) and predict mortality. Bigger. J. T. et al., ‘The Relationships 
slope would be zero. In order to obtain independent mea- Among Ventricular Arrhythmias. Left Ventricular Dysfunc- 
sures for statistical analyses. we established a procedure to tion and Mortality in the 2 Years After Myocardial 
evaluate the correlation between slope and log@ower) as a 60 Infarction,” Circulation 69:250-258. 1984; Bigger et al., 
function of frequency and locate the “zero-correlation” “Correlations Among Time and Frequency Domain Mea- 
point. We call the intercept at t h i s  point the “zero-correlation sures of Heart Period Variability TWO Weeks After Myocar- 
log@ower).” dial Infarction,” Am J. Cardiol. 692391-898,1992. Age was 
Statistical Procedures divided into three categories 4 0 ,  5CL59, 260. New York 
Survival Analytic Methods. We calculated Kaplan-Meier 65 Heart Association functional class was dichotomized at 
survival functions, see Kaplan et al.. “Nonparametic Esti- Class I or II versus IU or J.V. Rales were dichotomized at 
mation from Incomplete Observations. ”J. Am. Stat. Assoc. none or basilar versus greater than basilar. Left ventricular 
5.75 5.67 1 
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ejection fraction was coded on a 4-interval scale in accor- inverse power law relation between power and frequency. 
dance with the relation between ejection fraction and mor- indicated by a downward sloping straight line from lo4 to 
tality: ~0.20,0.20-0.29.0.30-0.39, and 10.40. The average lo-* Hz on the log-log graph. The slope of the regression 
frequency of ventricular premature complexes was also of log@ower) on Wfrequency) is somewhat stever for the 
coded on a cinbrval scale: none. 1 0  but 0 per how, 2 3  5 mYOCardid infarction patient and much steeper for the 
but 4 0  per hour, and 210 per hour. transplant patient (denervated heart) when compared with 
sets of analyses (iSe., v-ble alone and then the healthy subject. Compared with the area under the entire 
adjusted for five post infarction risk predictors+ead 24-hour RR interval Power Spectrum for the healthy subject, 
all-cause mortality, cardiac mortality, Or the area for the patient with recent myocardial infarction is 
about one-third and the area for the patient with a heart arrhythmic mortality as endpoints) were performed for the io transplant is about one-tenth. 
the log@ower) at lo4 Hz* and the zero-corre1ation 
lOg@OWer) as we’ as for the following power spec’‘ FIG. 2 compares the average regression fines for the three groups. n e  regression lines for the myomdial idarction 
measures: uLF Power (dichotomized at l600 m2)* vLF and transplant groups are shifted downward and are steeper 
power (dichotomized at 180 m2), power (dichotomized relative to the healthy group; both changes are significant. 
at 35 m2). HF power (dichotomized at 20 m2)* total power 15 The average slope oflog(power) on log(fiequency) indicates 
(dichotomized at 2000 m2)* These frequency measures that the decrease in power at higher frequency values is 
were analyzed in Order to Compare their Predictive Power much greater for the heart transplant group than for the 
with that of the Slope and Of the two measures of Spectral healthy group. These data are presented numerically in Table 
power. All variables were dichotomized to provide ease of 1. 
The above sequence of analyses (Le,. variable(s) alone 
and then adjusted for the above five risk predictors. using the 
three mortality endpoints) were performed using the follow- 
ing variables simultaneously: (1) the slope and the log 
interpretation. 20 
TABLE 1 
Power S&wtral  Measures of RR VarjabikIy for Healthy Middle-Ad 
Subjects (n = 274), Patients with Recent Myocardial Infarction 
(n = 715), snd Heart Transplant Patients (n = 19) (power) at lo4 Hz and (2) the slope and the zerwmrrelation 25 Power Mcasurc Healthy Post-Infalctim Transplant 
log@ower). This was done to assess the independent pre- 
104 Hzt adjusted for the above five risk predictors. 
poweT,mz 
improve positive predictive accuracy for all-cause mortality. 30 - 
variable.” Using the dichotomization cutpoints for each “Sc““) 
dictive power of both variables together. unadjusted and slept' -1.06 f 0.12 -1.15 It 0.19 -2.08 -t 0.22 
L4power) at 6.87 f 0.24 6.56 f 0.36 6 56 f 0.29 
To determine if power law spectral analysis would 
we combined slope and log@ower) at lo4 Hz into a “joint 21,222 f 11,663 7,623 f 6,049 3,716 f 3,410 
9.83 It 0.51 8.65 f 0.80 7.95 f 0.70 
18,420 f 10,639 6,280 + 5,089 3,678 f 3,357 
variable as described above, patients were categorized as LnllTLF) 9.68 f 0.54 8.45 f 0 80 794 f 0.70 
high risk by this “joint variable” if they were so categorized VLF 1,782 f 965 899 f 855 14f 28 
by both slope and logeower) at lo4 Hz. This enabled us to 35 7.35 f 0.53 6.36 f 1.03 2.09 f 0.94 
790 f 563 303 f 373 7 +  15 
6.45 f 0.68 5.08 f 1.22 1.03 * 1.22 
228 f 282 139 f 213 15 f 21 
zero-correlation log@ower). hW) 5.05 f 0.83 4.33 It 1.09 2.31 f 0.82 
4.61 f 2.33 2.77 f 2.12 0.32 f 0.20 
Total 
compare subjects at high risk by slope and log(power) at 
lo4 with a l l  other subjects. We did this also for slope and 
obtain an unbiased standard error of the mean (SEM) for the 40 hwm 
difference between two correlated relative risks. Miller, log(pwer) vQsus l o g ( ~ w n c y )  htWcen 10-4 and 10.2 
‘The Jackknife-A Review.” Biometrika 6l:l-15, 1974. HZ. 
One relative risk was obtained when both the slope and the 
~ ~ & ~ b e ~ ~ e ~ ~ $ ~ ~ ’ b ~ ~ m ~  law rewssion log@ower) at lo4 Hz were used as the components of a 
joint predictor of mortality. The second relative risk was 45 ULF. ultra low frequency; VLE very low frequency; LF, low 
obtained when the slope and the zero-correlation log@ower) frequency; IIF, high frequency. Ln denotes natural loga- 
were used together. These joint predictors were dichoto- rithm. 
mized; they were set to 1 if both variables were in the Values are mean B D .  
high-risk range, and to 0 otherwise. There was a correlation The average value for log@ower) at lo4 Hz for healthy 
between the log(p0wer) at lo4 Hz in one joint predictor and 50 middle-aged subjects is 6.87M.24 compared with 6.5633.36 
the zero-correlation log@ower) in the second joint predictor, for the myocardial infarction group (k15.82. p<O.OOOl) and 
resulting in an association between the two joint predictors. compared with 6.56M.29 for the heart transplant group 
In our analyses, the statistic jackknifed was the difference (t=20.19, p<O.OOOl; units of power are ms2/Hz). The aver- 
between the two relative risks. A SEM was derived. The age slope is -1.06s.12 for middle-aged healthy subjects 
difference between jackknifed relative risks, divided by the 55 compared with -1.15s.19 for the myocardial infaraion 
SEM. was referred for significance to a table of critical group (k8.99, p<O.OOOl) and compared with -2.08H.22 for 
values of the normal distribution. the heart transplant group (t4.56, ~ 4 . 0 0 1 ) .  Thus both 
Results slope and log@ower) at lo4 Hz are significantly affected by 
Power Law Parameters of the 24-Hour RR Interval Time myocardial infarction and the slope of the regression line is 
Series for Healthy Persons Compared with Those for the 60 profoundly affected by disease or denervation of the heart. 
Myocardial Infarction Group and with Those for the Heart The increase in the steepness of the average slope in 
Transplant Group (Denervated Hearts) diseased or denervated hearts indicates that the fractional 
FIGS. l(u)-(c) show 24-hour RR interval power spectra loss of power is substantially greater at higher frequencies. 
for a typical individual from each of the three groups we RGS. 3(u)+ show the frequency distributions for slope 
studied. In each example, the individual selected for display 65 of log(power) on log(frequency) and the point log(power) at 
had total power near the median for the group hdshe lo4 Hz for the healthy group. the myocardial infarction 
represented. The RR interval power spectra demonstrate the group, and the transplant grbup. Compared to the healthy 
LF 
Lno 
Jackknife Method We used the jackknife technique to 
1.41 f 0.51 0.75 f 0.78 -1.28 f 0.52 
18 
TABLE 2-continued 
5.755,67 1 
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group, the distributions for both variables in  patients with 
myocardial infarction are broader and extend further to the 
left, toward steeper slopes and lower values of log(power) at 
lo4 Hz. However, there is substantial overlap between the 
distributions of slope and log@ower) at lo4 Hz for the 
transplant patients have considerably steeper slopes than 
Correlations Among Power Spectral Measures of RR Variability for 
Healthy Middle-Aged Subjects (n = 274), Patients with Recent 
Acute Myocardial Infarction (n = 715), and Heart 
‘lhnwlant Patients (n = 191 healthy and myocardial infarction groups. Not only do 
either of the other groups, as seen in Table 1 and FIG. 2, but 
transplant group and the healthy group. The distribution of Measure Healthy tion plant Healthy tion Tiamplant 
0.249 0.323 0.863 0.348 0.506 4 . 1 9 0  log(power) lo4 Hz for the transplant group overlaps with 
that of the other groups. Ln(LF/HF) 0.052 0.410 0 . a  4 . 1 0 3  0.109 4 .169  
Slope+ bg(p0wer) at io4 Hzt 
Post Post also there is no overlap in the slope values between the 10 power Marc- lhns- Infarc- 
Ln(m;) 
*Slope of the log@ower) versus log(frequency) between lo4 and 
where p e r  is measured in units of ms2/Hz. 
ULF, ulha low frequency power; 
VLF, very low frequency power; 
By convention. the 24-hour RR interval power spectrum LF, low 
has been divided into four bands by integrating under 20 ~ k ~ k ~ w ~ l ~ ~ ~ & .  
segments of the spectrum. Total power is obtained by Power spectral values are logaritimiiauy t r a n s h d  to m& their 
integrating under the entire spectrum from about 0.00001 Hz dishibutions. 
to 0.04 Hz. Table 1 compares the new power law spectral The slope has only weak correlations with In(total power) 
measures of RR variability with previously published power or In(power1 in any frequency band. but the largest corre- 
spectral measures. Bigger. J. T. et al. ‘m variability in 25 lations are with the middle bands i n  the spectrum, ln(VLF 
best with ln(t0tal power) and with ln(ULF power). the 
spectrum. me correlations get progessively with 
Hz. 
correlations ~etween slope. Log(power) at lo4 HZ, and l5 thg(power) at 104 Hz computed from the power law regression equation, 
Log(Power) in Power Spectral Bands 
power; 
Hdthy, MiUe-AgedPersons Compared with Patients with 
Coronary Heart Disease Of Recent Acute Myocar- 
Power) and 
lowest frequency band under the =-how RR interval power 
power). Log@ower) at lo4 HZ 
dial Infarction,” Circulation 91:193&1943, 1995; Bigger et 
al.. “Correlations Among Time and Frequency Domain 30 higher frequency bands. 
Measures of Heart Period Variability Two Weeks After 
Myocardial Infarction,” Am. J. Cudiol. 698914398,1992; 
Bigger et al., “Correlations Among Time and Frequency 
Do& Measures of Heart period Variability %O Weeks 
mr my m dial ~ n f a r h ~ ~ , ”  
ences between the healthy group and the diseased groups 
T. et al., “RR variability in Healthy, Middle-Aged 
Compared with Patients with Chronic Coronary Heart Dis- 
ease of Recent Acute Myocardial Infarction,” Circulation 
91:1936-1943. 1995. Table 2 shows the correlations 
between each Power SF’ectral band we have Used for PrediC- 
tion Of 
the logbower) versus log(frequency) relationship between 
lo4 and Hz. as well as the correlations between each 
power spectral band and the log@ower) lo4 Hz. 
Location of ‘Bro-Correlation Log(P0wer)” 
FIG. 4 shows the correlation between slope and log 
(power) as a function of frequency in the myocardial inf- 
XdiOn group. w e  found that for lOWm Values O n  the 
J .  cadi0l. 69:891-898. 35 abscissa, e.g., lo4 Hz. log@ower) had a negative correla- 
negative) slopes tended to have higher power at lower 
frequencies. In contrast, we found that for higher values on 
40 with slope, i.e., patients with steeper slopes tended to have 
lower power at higher frequencies. over the range HZ 
to 1 H ~ .  the is &&bed by an s+haPed CUNe 
that passes bough zero once, i.e., 10-3.94 Hz, the 
frequency at which there is no correlation between log 
in Coronary heart disease and the Slop Of 45 (power) and slope for the 715 patients in the myocardial 
infarction group. 
Since there is no correlation between slope and the 
zero-correlation log(power), they should be multiplicative in 
predicting risk. Thus. it should be possible to estimate the 
50 mortality risk at 3 years for patients with high-risk values for 
both slope and zero correlation power by multiplying the 
relative risk of mortality for patients with high-risk values 
for slope, 2.92, by the relative risk for those with high-risk 
zero correlation values. 2.94. This procedure estimates a 
55 relative risk of 8.58. which is within the 95% confidence 
interval of the relative risk of 7.05, obtained directly from 
Power Marc- Trans- In$rc- Risk Prediction Based on Slope and The Zero-Correlation 
*sure Healthy tion plant Healthy tion T-plant Log(Power) used as Dichotomous Variables 
at lo-‘& 
Power, ms2 
1992. No statistid tests are presented to evaluate differ- tion with ’lop* In Other words* patients With steeper (more 
since this cowarison has been published Bigger, J* the abscissa. e.g. 10-2 Hz power had a positive 
TABLE 2 
correlations M e ~ s  Of RR variability for 
Healthy Middle-Aged Subjects (n = 274), Patients with Recent 
Acute Myocardial Infaxtion (n = 715), and Heart 
Transplant Patients (n = 19) 
b d w w e r )  at lo-‘ &t Slow* 
Post Post the Kaplan-Meier survival curves. 
bg(’m) 4 , 4 7 7  4 .216  4 .482  1.m 1.m 1.m The best for prediding risk after 
infarction with the slope of the power spectral regression 
line was -1.372; patients with steeper slopes, i.e.. more 
negative values, were at greater risk, The best cutpoint for 
LnfJotal) 0.023 0.258 0.332 0.617 0.759 0.445 death after myocardial with the log Ln(ULF) -0.037 0.176 0.314 0.598 0.759 0.459 
~ ( V L F )  0,371 0,612 0.803 0,575 0.605 0.089 65 (power) lo4 Hz was 6.345. The best cutpoint for predicting 
J-n(LF) 0.345 0.552 0.838 0.350 0.522 -0.200 death after myocardial infarction with zero-correlation log 
Hz) was 5.716. Power is (power) (log(power) at 
5,755,671 
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measured in units of ms2/Hz. Note that for zero-correlation 
logeower), the frequency at which it is computed is data- 
dependent. To be applied to a different population. this 
frequency. in  addition to its cutpoint, would have to be 
computed with a representative sample of that population. 
Table 3 lists the variables slope. log@ower) at lo4 Hz. and 
zero-correlation log@ower) at their optimum cutpoints. the 
numbers of patients in the groups categorized as having low 
or high values for the variable, and the Kaplan-Meier 3-year 
all-cause mortality rates for patients in the high and low 
categories for each variable. 
TABLE 3 
20 
Strength of association (relative risk) and statistical of 
significance of association are shown in Table 4. 
Table 4 shows the significance (Z value) and strength of 
association (relative risk) obtained from the Cox regression 
analysis for the slope, the log@ower) at lo4 Hz and 
zero-correlation log@ower). all dichotomized. and three 
mortality endpoints. all-cause, cardiac, and arrhythmic 
death. 
~~~ ~~ ~ ~~ ~ ~ 
Cutpoints Used to Dichotomize Power Law Regressim Parameters for Post-Infarction 
Mortality Analyses (n = 7151 
Below Cumint At or Above CutDoint 
Pcrccnt Kaplan-Meii Kaplan-MCk 
Below 3 Year 3 Year 
Wable Cutpoint Cutpoint N MortalityRate N MortalityRate 
Slope* -1.372 10.8% 77 41.5% 638 14.2% 
k3(pawa)  at 6.345 26.4% 189 32.6% 526 11.7% 
zcrOcorrclation 5.716 119% 102 40.0% 613 13.4% 
104 Hzt 
log@ow=)S 
*Slope of the log(p0wcr) vmus log(fr0qucnCy) between lo4 and 
tbg@owcr) at IO-' Hz iF, computed h m  the power law regression equation, wherr power is 
n r d  in units of d / H Z .  
Dg@owm) at lo3.= Hz computed from the power law rcgrrssion equation, where power 
is m e a s 4  in tmits of ms2/HZ. For the Post Infarction sample, 1pSw Hz is tk fnsuency at 
which there is no correlation between slopc and log@nver). 
Hz. 
TABLE 4 
Rcdiaion of Aucause Mortality After Myocardial Infar+tion by Power Spectral Mea~rt~c~  of 
RR Variability Beforr and After Adjusting for Othcr Post Iafa~~tion Risk Predictors* 
Us& Cox Rearessim Analvsis (n = 7 15) 
Mortalitv 
All casts (119 Deaths) Gudiac (88 Deaths) Arrhwimic (68 Deaths) 
Unadiustcd Adiusted Unadiustad A d i d  Unadiustrd Adiusted 
Relative Relative RClatiVC Relative Relative Relative 
Variable zt Risk$ zt RisLS zt R&$ zt Risk$ zt Risks zt Risk 
Total 
ULF 
VLF 
LF 
HF 
wm 
5.61 3.40 2.57 1.86 5.42 3.83 2.79 2.11 5.35 4.42 3.02 2.51 
6.37 3.29 3.55 2.05 5.49 3.30 2.68 1.89 4.60 3.15 2.21 1.82 
6.49 3.66 3.28 2.08 5.95 3.95 2.82 2.07 4.57 3.45 2.03 1.86 
6.79 4.14 3.16 2.12 5.47 3.90 2.36 1.91 4.62 3.79 2.08 1.95 
7.33 4.76 3.94 2.58 6.21 4.76 3.45 2.60 5.31 4.71 3.07 2.69 
6.63 3.77 2.31 1.70 6.11 4.11 2.04 1.72 5.64 4.41 2.28 2.00 
5.18 3.09 1.74 1.53 5.11 3.56 1.85 1.66 4.62 3.69 1.94 1.84 
3.42 2.23 1.62 1.50 3.56 2.59 1.94 1.72 2.84 2.39 1.70 1.72 
4.67 2.69 2.0s 1.60 3.51 2.42 1.30 1.42 3.35 2.61 1.44 1.56 
'Adjusted for age, New York Heart Assucisrion functional claas. A s ,  left ventricular ejection fraction aod average fnsucncy 
of ventricular premafum 
tZ 5 1.96, p < 0.05; Z S ~ ~ ? O . O l :  2 5 3.30, p < 0M)l 
$Relative risk i the probability of dying if below the cutpoint divided by the pmbab&iy of dying if above the cutpoint. 
*Slop of tbt log(powa) ycrsus I o g ( h y ~ ~ ~ ~ y )  between le and lo-* Hz, dichotomized as shown in Table 3. 
k.og@wm) at lo4 & computed from th power law regression cquatim, w h  power is m u r e d  in units of ms2/&, 
dichotomized as shown in Table 3. 
5,755,67 1 
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Log@owerj at 10-3.594 Hz computed from the power law was no statistically significant difference between the two 
regression equation, where power is measured in units of relative risks (z0.86; NS). This indicates that log@ower) at 
ms2/Hz. For the post infarction sample, 10-3.s4 Hz is the lo4 Hz and slope provide predictive power similar to 
frequency at which there is no correlation between slope and zero-correlation log(power) and slope. 
power. This variable is dichotomized as shown in Table 3. 5 To determine the joint predictive value of the two power 
For comparison. the power spectral bands used for risk law regression parameters (slope and log@ower) at lo4 Hz) 
prediction after myocardial infarction also are tabulated. for all-cause mortality, we cross-classified the MPIP sample 
Each power spectral variable was evaluated individually in using the two regression parameters and displayed the 
a Cox regression model. Table 4 also tabulates the sign& survival experience graphically using the Kaplan-Meier 
cance (Z value) and strength of association (relative risk) io method (FIG. 5). Each patient was classified as high risk on 
after adjusting for the five risk predictor covariates that we neither, either, or by both slope and log@ower) at lo4 Hz. 
have previously found to be strongly associated with mor- Fully 66% of the patients were classified as low risk on both 
tality. The slope, the log@ower) at lo4 Hz. and zero- parameters and only 21 (3%) patients were in the high risk 
correlation log@owerj all have associations with the three category for both slope and log(p0wer) at lo-4 Hz. The 
mortality endpoints that are comparable with the power in  15 3-year actuarial survival rates for the four groups were: low 
the spectral bands that have been used for risk prediction risk on both variables. 89%; high risk on slope, 64%; high 
after myocardial infarction. risk on log@ower) at lo4 Hz, 70%; and high risk on both 
Table 5 shows the significance (Z value) and strength of slope and log(power) at lo4 Hz. 17%. 
association (relative risk) for the slope and each power FIG. 6 shows similar Kaplan-Meier curves for the four 
measure, all dichotomized, with three mortality endpoints, 20 subgroups cross-classified by slope and the zero-correlation 
all-cause. cardiac, and arrhythmic death when the slope and log@ower). There were 102 (14%) with a zero-correlation 
one of the two power measures are entered simultaneously logmwer) less than 5.716 log(ms2Wz). Sixteen (2%) 
into a Cox regression model. patients were in the high risk category for both slope and 
TABLE 5 
Rodictioo of AllCausc Mortality Aftcr Myocardial Infarction with Power Law Regression Parameters 
Using Cox RegressbnModcls with and Without Adjusting for Other Post Infarction Risk Predictors. (n = 7 1Sj 
TWO Modcls are S k  tht Fm Includes both Slope and the Logpower) ar lo4 Hz; 
the Second Model Includes both Slope and tbe ZeroComlatim LnxPower) 
All Cases (119 Deaths) Cardiac (88 Deaths) Arrhythmic (68 Deaths) 
Undiustcd Adiustcd Unadjusted Adjusted Unadiustcd Adiusted 
Relative Relative Relative Relative Relative Relative 
Variable Zt Risk$. Zt Risk$. Zt Risk$ Zt Risk$ Zt Risk$ Zt Risk 
6.28 4.01 3.49 2.31 5.93 4.43 3.60 2.70 5.72 4.98 3.72 3.21 
6.86 3.64 4.20 2.39 5.90 3.65 3.44 2.31 4.95 3.46 3.01 2.33 
Slop' 5.75 3.51 3.00 2.07 5.44 3.86 3.20 2.37 5.32 4.39 3.32 2.75 
Zcm-wmlation 6.61 3.75 3.63 2.25 5.97 3.97 3.22 2.30 4.53 3.43 2.44 2.11 
sfopes 
Lodower) 
10-4 HZ" 
log@ow4 
~ 
*Adjwted for age, New Ywk Hcart Association functional class, rales. left vcnlricular ejection fraction and average hquemy 
of ventricular premature complcxcs. 
tZ S 1.96, p < 0.05; Z S 2.58, p < 0.01; Z 5 3.30, p < 0.W1 
$Relative risk is the probability of dying if below the cutpoint divided by the probability of dyiag if above the cutpoint. 
sSlope of the log(p0wer) vmus log(fnqmy) between lO-' and lo-' Hz, dichotomized as shown in Table 3. 
b g ( p w e r )  at IO-' HZ computed from the power law regression equation, w h m  power is mcasur~d in units of ~&Hz, 
dichotomized as shown in Table 3. 
Log@ower) at 594 Hz computed from the power law zero-correlation log(power). The 3-year actuarial survival 
regression equation, where power is measured in units of for the four groups were: low risk on both variables, 89%; 
ms2/Hz, dichotomized as shown in Table 3. For the post high risk on slope, 67%; high risk on zero-correlation 
infarction sample, 10-3."4 Hz is the frequency at which log@owerj. 67%; and high risk on both slope and zero- 
there is no correlation between slope and power. 
The strength and significance of the slope and a power Risk Prediction Based on Joint Variables from Power Law 
measure in the multivariate model are similar to those found Regression Analysis 
in the univariate models, reflecting a low correlation The slope and zero-correlation log@owerj were used as 
between these variables, Patients in  the higher risk category components of joint predictor variables in Cox re ession 
for the slope and a power measure are at very high risk For analyses. as were the slope and log@owerj at 10pHz. In 
example, the relative risk for all-cause mortality is 14.40 these analyses, patients classified as high risk by slope and 
(4.01~3.64) for patients who are categorized as high risk by the log@ower) at lo4 Hz had a relative risk of 10.16 
both slope and the logbower) at lo4 Hz. (p<O.OOl); patients classified as high risk by slope and the 
When we used the jackknife technique to compare the zero-correlation log@ower) had a relative risk of 11.23 
relative risk for patients with high risk values for both the (pc0.001). When the joint variable comprised of slope and 
slope and the log@ower) at lo4 Hz to the relative risk 65 the log@ower) at lo4 Hz was adjusted for age. New York 
obtained for patients with high risk values for both the slope Heart Association functional class. left ventricular ejection 
and the zero-correlation log@ower). it was found that there fraction, and average frequency of ventcicular premature 
50 
55 correlation log@ower). 21%. 
5,755,67 1 
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complexes, the relative risk was 6.07 @<0.001). When the 
joint variable comprised of slope and the zero-correlation 
log@ower) was so adjusted. the relative risk was 5.57 
When ULF and VLF were similarly combined into a 
variable indicating high-risk classification for both ULF and 
VLF. the resulting variable had a relative risk of 4.85 
@<0.001). When adjusted in the same manner as the joint 
variables comprised of the 2 power law measures, the 
relative risk was 2.98 @<0.001). This was considerably 
lower than the relative risk for the joint variables comprised 
of the 2 power law measures. 
The purpose of this study was to quantify the power law 
aspect of the 24-hour RR interval time series in healthy 
subjects. i n  denervated (transplanted) hearts, and in patients 
with recent myocardial infarction, and to determine the 
ability of power law regression parameters to predict death 
after myocardial infarction. From preliminary studies. the 
spectral power of RR interval fluctuations seemed to be an 
inverse, linear function of frequency from somewhat above 
Hz to below la-4 Hz in a log-log graph. Based on 
these preliminary observations, we decided to fit a linear 
regression to log(power) as a function of log(f?equency) 
between lo4 and lo-’ Hz. We found that this relation in fact 
was linear. i.e.. the goodness of fit was excellent in healthy 
subjects. i n  patients with denervated hearts. and in patients 
with recent myocardial infarction. 
The slope computed over the two-decade band lo4 to 
lo-’ Hz is a fundamentally different RR interval power 
spectral measure than the standard band power components 
ULF. VLE LE or €IF. In contrast to these. the slope reflects 
not the magnitude but rather the distribution of power in t h i s  
two-decade region. The average slope was close to -1 for the 
healthy middle-aged subjects in our study. A slope of exactly 
-1 on a log-log graph (where a in equation [ 11 is equal to 
-1) means that spectral power is proportional to the recip 
r o d  of frequency. In other words, there is a unit decrease 
in power for every unit increase in frequency. A slope of -1 
also means that power in the lower decade, lo4 to Hz. 
is equal to power in the higher decade, to lo-’ Hz. But 
since the width of the lower decade is one-tenth that of the 
higher. the spectral density in the lower decade, expressed as 
power per unit frequency (in th is  case ms’/Hz), is tea times 
that of the higher decade. The steeper the slope, the greater 
the power in the lower frequency ranges relative to the 
higher frequency ranges. 
These frequency-domain featwes--linearity and slope 
near-1-have implications in the time domain. First. the 
variance of relatively rapid RR interval oscillations with 
periods from 100 seconds to 1000 seconds (i.e.. approxi- 
mately 2 to 20 minutes. corresponding to lo-’ to 10” Hz) 
will equal the variance of much slower oscillations with 
periods from loo0 to 1O.OOO seconds (i.e., up to about 3 
hours, corresponding to lo4 Hz). Thus. plots of RR interval 
versus time over 2 minutes, 20 minutes, and 3 hours may 
ajipear similar. This feature. called scale invariance or self- 
similarity, distinguishes a broad-band frequency spectrum. 
wherein no single frequency component characterizes a 
signal. from a narrow-band spectrum as might be found, for 
example. in the HF power band of the RR intmal power 
spectrum during metronome breathing. Fractal mathematics. 
well-suited to describe such scale-invariance signals. has 
already been applied in an exploratory fashion to RR inter- 
val time series analysis, see, Goldberger et al.. “Fractals in 
physiology and Medicine,” Yale J. BioL Med. 60:421-435, 
1987. and might be used for risk-stratification in larger data 
sets. 
(p<o.oo 1). 
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Because power is an inverse function of frequency. RR 
interval variance is a direct function of time. i.e.. variance 
increases with the length of observation, another feature of 
a broad-band spectrum In contract. the variance of a signal 
5 with a narrow-band spectrum, such as a sine wave, closely 
approaches a constant value after the length of observation 
encompasses a few cycles. Therefore. RR interval variance. 
or its square root, SDNN, is meaningful only with respect to 
a particular duration of electrocardiographic recording. This 
io is true whether the slope of the log-transformed power 
spectrum is -1 as in the healthy sample or -2 as in the 
denervated heart (patients with heart transplants). One 
implication of the power law relation between spectral 
power of RR interval fluctuations and their frequency is the 
15 need to correct SDNN for differences in the duration of 
Holter ECG recordings. 
EfFect of Myocardial Infarction and Cardiac Transplantation 
on Power Spectral Regression Parameters. 
Io normal middle-aged subjects, the slope of the log 
U ]  bower) on log(frequency) regression line is very close to 
-1. Myocardial infarction and cardiac transplantation 
(denervation) shift the entire regression line down. Le.. 
power spectral density is decreased at any frequency (FIGS. 
3(a)+). The average slope of the regression line is much 
25 steeper (about -2) for patients with heart transplants 
(denervated) than for age- and sex-matched healthy subjects 
(average slope about -1). Thus, the range of the slope is 1 
when comparing healthy, innervated hearts to transplanted 
denervated hearts. The average slope of the regression line 
30 for patients with myocardial infarction is closer to values for 
healthy subjects (about -1.15) than to values for 
transplanted denervated hearts. However, after myocardial 
infarction, the values for the slope vary from normal at one 
extreme of the distribution to values that approach those of 
35 the transplanted, denervated hearts at the other end of the 
distribution. The change in the slope when the heart is 
denervated by transplantation suggests that the slope is 
substantially influenced by the heart’s autonomic inputs. 
The Correlation between Power Spectral Regression Param- 
40 eters and Other Power Spectral Measures of RR Variability. 
FIG. 7 diagrams the relationship between the power law 
regression line and traditional power spectral bands for a 
healthy subject. Table 2 shows that there is very little 
correlation between any of the four power spectral bands 
4s and the slope of log@ower) on log(frequency). There is a 
greater but st i l l  moderate correlation between log@ower) at 
lo4 Hz and the power spectral bands. Because the two 
power law regression parameters, slope and log@ower) at 
lo4 Hz, correlate only moderately with traditional power 
M spectral bands (Table 2). the two regression parameters have 
the potential to predict risk better than the power spectral 
bands. 
Slope and Intercept as Risk Predictors after Myocardial 
Infarction. 
As shown in Table 4, slope and log@ower) are significant 
and independent predictors of all-cause mortality. when 
adjusted for five post infarction risk predictors which we 
have previously found to be strongly associated with mor- 
60 Association Between Power Law Regression Parameters 
and Mortality. 
In a previous study, we examined the association between 
mortality and four bands of the RR interval power spectrum 
as well as total power and LF/HF ratio (11). An analysis of 
65 the relationship between log(power) and log(frequency) 
produces two variables which reflect not only the magnitude 
but the frequency-dependence of the power spectral curve in 
55 
tality. 
5,755.671 
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the range lo4 Hz to lo-* Hz, frequencies corresponding to 
cycles of 2.7 hour and 1.7 minutes, respectively. This 
frequency range includes parts of the ultra low and the very 
low frequency bands. which were found to have a strong 
association with mortality. 
slope and log@Ower) are not independent, but are nega- 
tively correlated for lower values on the abscissa and 
positively correlated for higher values on the abscissa (mG. 
4). By calculating the zero-correlation log@ower), we 
obtained two statistically independent variables, thereby 
maximizing the information obtained about the slope and lo comprising: 
of the power Spectral Cm~e. we did Similar 
correlation log@ower). When used individually. the predic- intervals corresponding to time intervals between heart 
tive value of slope and power measures were close to the beats; and predictive value of ultra low frequency or very low fre- 15 quency men into joint variables indicat- analyzing long-time structure of fluctuation in the inter- 
ing high risk classification for slope and zero-correlation vals to assess risk of an adverse clinical event. 
relative risks of these joint variables were very high, Le.. 
>lo. The relative risks were high. ,5 after these joint 
variables were adjusted for age. New York Heart Association 2o 
functional class, left ventricular ejection fraction, and aver- 
age frequency of ventricular premature complexes. 
and VJJ were similarly combined into a 
variable indicating high-risk classification for both ULF and 
VLF. the joint variable had a relative risk 6. When the 25 the intervals. 
ULF-VLF joint variable was adjusted for other post infarc- 
tion risk predictors, the relative risk was <3. Thus, the ULF 
and VLF bands. the strongest predictors of the power 
spectral bands tested. have much lower joint predictive 
power than the joint variables comprised of the 2 power law 30 
measures. This is because of the strong correlation between 
the logarithmically transformed variables ULF and VLE 
which is 0.75, as contrasted with the lack of correlation 
between the slope and zero-correlation log@ower), and the 
considerably lower correlation of 0.48 between the slope 35 
and iOg@Ower) at lo4 Hz' For this reason' the 
provided by ULF and VLF is substantially redundant and, as 
a result, there is less gain in predictive value when they are frequency range* 
combined. 
Apparatus approximately IO4 to Hz. 
now be described in conjunction with FIGS. 8 and 9. A 
human subject 102 has had electrodes 104 applied for 
recording ele&om&ographic activity. wires 106 bring the 
electrocardiographic signals to portable recording apparatus 
108. A belt 107 is used to hold the portable recording 45 a predetermined risk-related cutpoint amplitude. 
apparatus 108 on the subject 102. The portable recording 
apparatus 108 ampLifies the electrocardiographic signals 
from the electrodes 104 and records them on magnetic tape. 
It is contemplated that the subject 102 will wear the portable 
recording apparatus 108 for an extended period of time such 50 predetermined risk-related cutpint exponent. 
as for twelve to twenty-four hours. 
analyses may be recorded on paper. The output of the 
computer 116 provides an assessment of risk of an adverse 
clinical event as discussed in detail throughout th is  specifi- 
cation. 
It is recognized that moditications and variations of the 
present invention W f l  OCCUT to those skilled in the art and it 
is intended that all such modifications and variations be 
included within the scope of the appended claims. 
What is claimed is: 
1. Method for assessing risk of an adverse clinical event 
detecting a physiologic signal in a subject; 
using l0g@Ower) at lo4 HZ instead Of zero- determining from the physiologic signal a sequence of 
log(power), or for slope and log@owa) at lo4 Hz, the 2. The method Of claim wherein Physiologic signal 
is an electrOCardio@m* 
3. The method of claim 2 wherein the interval is the RR 
4. The method Of wherein the sequence Of 
intervals spans a time period of at least fifteen minutes. 
5. The method Of Claim 1 wherein the analyzing Step 
involves computing the power spectrum of the fluctuation in  
6. The method of claim 5 wherein the amplitude of the 
power spectnun, at a specified frequency. is estimated, the 
amplitude of the power spectrum at the specified frequency 
being related to the risk of an adverse clinical event. 
7. The method of claim 6 wherein the specified frequency 
is qpro-kly 10-4 H ~ .  
8. The method of claim 6 further including the step of 
the amplitude of the power spectrum with a 
pr&etedned risk-rehted cutpoint 
fder involving fitting the 
power spectrum to a power law dependence on frequency, 
Over a 
10. The method of claim 9 wherein the frequency range is 
ne for -ing out the invention 40 11. The method of claim 9 in which the amplitude of the 
at a specified fie- 
12. The method of C h h  9 further including the step of 
When 
9. The method of claim 
power law &penden= is 
quencY. 
comparing the amplitude of the ~ w e r  law dependence with 
13. The method of claim 11 wherein the specified fre- 
quency is approximately 10-4 Hz. 
14. The method of claim 9 wherein an exponent charac- 
texizing the power law dependence is compared with a 
15. The method of claim 5 further involving fitting the 
logarithm of the power spectrum to a linear dependence on After recording from the subject 102. a Player 110 is 
used to play magnetic W e  112 on which the e lec t romdi~~ 
gaphic signals have been recorded by the pmb1erecor'% the logarithm of frequency, over a selected frequency range. 16. The method of claim 15 wherein the frequency range apparatus 108. Signals from the tape playback unit 110 are 55 is approximately 
computer 116 also contains an analog-to-digital conversion 
board which converts analog electrocardiographic signals to 
digital form for analysis. The computer 116 processes the 
electrocardiographic signals recorded on the magnetic tape 
112. In particular, the computer 116 is adapted to detect R 6o predetedned 
waves of the electrocardiogram. compute interbeat intervals, 
and perform the analyses of the long-time structure of the 
fluctuations in the intmals discussed above in this spdfi-  
cation. A video monitor 118 may be provided to display the 
results of the analyses performed by the computer 116. 65 risk-related cut-point slope. 
Similarly, the computer 116 may be connected to a printer 
122 via a printer cable 12Q so that the results of the computer 
to 10-2 Hz. canied '14 to a general purpose 'OWuter '16* The 17. The method of claim 15 in which amplitude of the 
linear dependence is 
the step Of 
'Omparing the amplitude Of the linear &pendence with a 
19. The method of claim 17 wherein the specified fre- 
¶uencY is aPFoximtelY lo4 Hz. 
20. The method of claim 15 wherein slope charactexizing 
the linear dependence is compared with a predetermined 
21. The method of claim 15 applied to a reference 
population further including determining a frequency within 
at a specified frequency. 
The method Of claim l7 further 
cutpint ampfitude* 
5,755.671 
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the selected frequency range at which amplitude of the linear 
dependence has a low correlation with slope of the linear 
dependence. 
22. The method of claim 1 wherein the physiologic signal 
is detected while the subject is ambulating. 
23. The method of claim 1 wherein the physiologic signal 
is detected while the subject is engaged in an activity 
24. Method for assessing risk of an adverse clinical event 
detecting an electrocardiogram signal in a subject; 
determining from the electrwardiogram a sequence of 
intervals corresponding to time intervals between heart 
beats; 
computing the power spectrum of the sequence of inter- 
vals over a time period of more than 6 hours: 
fitting the logarithm of the power spectrum to a linear 
dependence on the logarithm of frequency over the 
frequency range of approximately lo4 to lo-' Hz.; and 
assessing risk based on one or more characteristics of the 
linear dependence. 
25. The method of claim 24 wherein one of the charac- 
teristics includes slope of the linear dependence. 
26. In the method of claim 25 wherein one of the 
characteristics includes amplitude of the linear dependence 
at a specified kquency. 
27. Apparatus for assessing risk of an adverse clinical 
event comprising: 
electrodes responsive to physiologic signals in a subject to 
generate output signals; 
electronic apparatus for receiving the output signals and 
for analyzing long-time structure of fluctuations in 
intervals between heartbeats over a time period of more 
than 15 minutes to assess risk of an adverse clinical 
event. 
28. Apparatus for assessing risk of an adverse clinical 
recording apparatus adapted to record a physiologic signal 
in a subject; and 
electronic apparatus for analyzing the physiologic signal 
to determine long-time structure of fluctuations in 
intervals between heartbeats. the electronic apparatus 
further adapted for assessing risk of an adverse clinical 
event. 
29. Apparatus for assessing risk of an adverse clinical 
apparatus for detecting a physiologic signal in a subject; 
means for determining from the physiologic signal a 
sequence of intervals corresponding to time intervals 
between heartbeats; and 
electronic apparatus for analyzing long-time structure of 
fluctuations in the intervals to assess risk of an adverse 
clinical event. 
30. The apparatus of claim 27,28 or 29 wherein the time 
period is at least one hour. 
31. The apparatus of claim 27, 28 or 29 wherein the 
analyzing involves computing the power spectrum of fluc- 
tuations in the intervals. 
32. The apparatus of claim 31 further involving fitting the 
proSOCOl. 
comprising: 
event comprising: 
event comprising: 
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intervals between heartbeats and assessing risk of an adverse 
clinical event based on an analysis of the long-time structure 
of fluctuations in the intervals. 
35. The method of claim 34 further involving obtaining at 
5 least two measures of the fluctuations. 
36. The method of claim 34 further comprising the step of 
computing serial  auto-correlation coefficients of the fluctua- 
tions in intervals between heartbeats. 
37. The method of claim 34 further involving the com- 
10 putation of a power spectrum of the fluctuations in intervals 
38. The method of claim 34 further involving a frequency 
39. The method of claim 34 further involving the com- 
15 putation of the magnitude of the fluctutations in at least two 
frequency bands, at least one of which includes a region 
below 0.02 Hz. 
40. The method of claim 34 further involving the com- 
putation of the magnitude of fluctuations at, at least. two 
41. The method of claim 34 further involving auto- 
regressive analysis of fluctuations in intervals between 
heartbeats. 
42. The method of claim 34 further involving analysis of 
the fluctuations over at least two merent length segments of 
43. The method of claim 42 wherein the analysis involves 
computation of the standard deviation or variance of inter- 
vals in the segments. 
44. The method of claim 43 wherein the analysis involves 
30 computation of the average of NN intervals in the segments. 
45. The method of claim 1 wherein the physiologic signal 
is detected while the subject is resting. 
46. The method of claim 42 wherein the analysis involves 
analyzing the variability of the intervals within segments of 
47. The method of claim 42 wherein the analysis involves 
analyzing the variability between segments containing inter- 
beat intervals of a measure of the intewals within segments. 
48. A method for assessing risk of an adverse clinical 
40 event comprising analyzing the long term frequency depen- 
dence of fluctuations in intervals between heartbeats includ- 
ing at least two frequencies, one of which is below 0.02 Hz, 
the frequency dependence being related to risk of an adverse 
clinical event. 
49. The method of claim 34 further involving the com- 
putation of an autc+correlation function of the fluctuations in  
intervals between heartbeats. 
50. The method of claim 34 further involving Fourier 
analysis of fluctuations in intervals between heartbeats. 
51. The method of claim 34 further involving wavelet 
50 analysis of fluctuations in intervals between heartbeats. 
52. The method of claim 34 further involving polynomial 
analysis of fluctuations in intervals between heartbeats. 
53. The method of claim 34 further involving Hankel 
analysis of fluctuations in intervals between heartbeats. 
54. The method of claim 34 further involving complex 
demodulation analysis of fluctuations i n  intervals between 
heartbeats. 
55. A method for assessing risk of an adverse clinical 
event comprising analyzing the variability in intervals 
60 between heartbeats utilizing segments of interbeat intervals 
of at least two merent lengths; and assessing risk from the 
between heartbeats. 
analysis of the intervals between heartbeats. 
2o frequencies, at least one of which is below 0.02 Hz. 
25 an interbeat interval sequence. 
35 a sequence of interbeat intervals. 
45 
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power spectrum to a power law dependence on frequency 
over a selected frequency range. 
33. The apparatus of claim 32 wherein the selected 
frequency range is approximately lo" to lo-' Hz. 
34. Method for assessing risk of an adverse clinical event 
variability in intervals. 
56. The method of claim 55 wherein the analysis involves 
analyzing the variability between segments of interbeat 
65 intervals of a measure of the intervals within segments. 
comprising analyzing long-time structure of fluctuations in * * * * *  
